Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) found in marine fish oils are known to suppress inflammation associated with a wide variety of diseases. Eicosapentaenoic acid (EPA) is one of the most abundant ω-3 fatty acids in fish oil, but the mechanism(s) by which EPA exerts its beneficial effects is unknown. Recent studies, however, have demonstrated that oxidized EPA, rather than native EPA, possesses antiatherosclerotic, anti-inflammatory, and antiproliferative effects. Very few studies to date have investigated which EPA oxidation products are responsible for this bioactivity. Our research group has previously reported that anti-inflammatory prostaglandin A 2 -like and prostaglandin J 2 -like compounds, termed A 2 /J 2 -isoprostanes (IsoPs), are produced in vivo by the free radical-catalyzed peroxidation of arachidonic acid and represent one of the major products resulting from the oxidation of this PUFA. Based on these observations, we questioned whether cyclopentenone-IsoP compounds are formed from the oxidation of EPA in vivo. Herein, we report the formation of cyclopentenone-IsoP molecules, termed A 3 /J 3 -IsoPs, formed in abundance in vitro and in vivo from EPA peroxidation. Chemical approaches coupled with gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS) were used to structurally characterize these compounds as A 3 /J 3 -IsoPs. We found that levels of these molecules increase approximately 200-fold with oxidation of EPA in vitro from a basal level of 0.8 ± 0.4 ng/mg EPA to 196 ± 23 ng/mg EPA after 36 hours. We also detected these compounds in significant amounts in fresh liver tissue from EPA-fed rats at basal levels of 19 ± 2 ng/g tissue. Amounts increased to 102 ± 15 ng/g tissue in vivo in settings of oxidative stress. These studies have, for the first time, definitively characterized novel, highly reactive A/J-ring IsoP compounds that form in abundance from the oxidation of EPA in vivo.
Omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) found in marine fish oils are known to suppress inflammation associated with a wide variety of diseases. Eicosapentaenoic acid (EPA) is one of the most abundant ω-3 fatty acids in fish oil, but the mechanism(s) by which EPA exerts its beneficial effects is unknown. Recent studies, however, have demonstrated that oxidized EPA, rather than native EPA, possesses antiatherosclerotic, anti-inflammatory, and antiproliferative effects. Very few studies to date have investigated which EPA oxidation products are responsible for this bioactivity. Our research group has previously reported that anti-inflammatory prostaglandin A 2 -like and prostaglandin J 2 -like compounds, termed A 2 /J 2 -isoprostanes (IsoPs), are produced in vivo by the free radical-catalyzed peroxidation of arachidonic acid and represent one of the major products resulting from the oxidation of this PUFA. Based on these observations, we questioned whether cyclopentenone-IsoP compounds are formed from the oxidation of EPA in vivo. Herein, we report the formation of cyclopentenone-IsoP molecules, termed A 3 /J 3 -IsoPs, formed in abundance in vitro and in vivo from EPA peroxidation. Chemical approaches coupled with gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS) were used to structurally characterize these compounds as A 3 /J 3 -IsoPs. We found that levels of these molecules increase approximately 200-fold with oxidation of EPA in vitro from a basal level of 0.8 ± 0.4 ng/mg EPA to 196 ± 23 ng/mg EPA after 36 hours. We also detected these compounds in significant amounts in fresh liver tissue from EPA-fed rats at basal levels of 19 ± 2 ng/g tissue. Amounts increased to 102 ± 15 ng/g tissue in vivo in settings of oxidative stress. These studies have, for the first time, definitively characterized novel, highly reactive A/J-ring IsoP compounds that form in abundance from the oxidation of EPA in vivo.
Eicosapentaenoic acid (C20:5, ω-3; EPA) 1 is one of the most abundant omega-3 polyunsaturated fatty acids (PUFAs) present in fish oils. Both animal and human epidemiological studies, and more recently, human clinical intervention trials, suggest that fish consumption, or dietary fish oil supplementation, reduces the incidence of important diseases including atherosclerosis and sudden cardiac death, neurodegeneration, asthma, and other inflammatory disorders (1) (2) (3) . The mechanism(s) by which this effect occurs is unknown, but it has been hypothesized that both various enzymatically and non-enzymatically-derived EPA oxidation products are responsible for some of the benefits associated with EPA (4-7). While specific biologically active, enzymatically-derived EPA oxidation products such as polyhydroxylated EPA derivatives termed the resolvins have been reported by Serhan and colleagues, no studies to date have determined which non-enzymatic oxidation product or products of EPA might contribute to its bioactivity. A recent report from our lab, however, determined that EPA peroxidation products containing α,β-unsaturated carbonyl ring structures induced the NF-E2 related factor 2 (Nrf2)-based antioxidant response through inhibition of a negative regulator of Nrf2, but this study did not definitively characterize the molecular structure of these compounds (8) .
Isoprostanes (IsoPs) are prostaglandin (PG)-like molecules that are formed nonenzymatically from the free radical-induced oxidation of arachidonic acid (C20:4, ω-6). These compounds are generated via bicyclic endoperoxide PGH 2 -like intermediates that are reduced to PGF 2α -like compounds termed F 2 -IsoPs or the endoperoxides can undergo rearrangement to PGE 2 and PGD 2 -like compounds (E 2 /D 2 -IsoPs) (9, 10) . Unlike PGs, however, IsoPs have been shown to form in situ in phospholipids and are subsequently cleaved from phospholipid storage sites by phospholipases (11, 12) . It is well known that eicosanoids containing E-and D-type prostane rings are unstable and readily dehydrate in aqueous solutions to form cyclopentenonecontaining compounds (13) . Previously we reported that, analogous to the formation of A-ring and J-ring PGs from the dehydration of the cyclooxygenase-generated PGE 2 and PGD 2 , A 2 /J 2 -IsoPs as well as A 4 /J 4 -neuroprostanes (NPs), are generated in vitro and in vivo from the oxidation of arachidonic acid and docosohexaenoic acid (C22:6, ω-3; DHA), respectively (13) (14) (15) . More recently, our laboratory has confirmed that F-ring IsoP-like compounds, termed F 3 -IsoPs, are also formed from the free radical-catalyzed peroxidation of EPA (16) . Based on these studies as well as our interest in the potential bioactivity of cyclopentenone-containing EPA oxidation products, we have hypothesized that, analogous to the formation of A 2 /J 2 -IsoPs from the oxidation of arachidonic acid, A-and J-ring IsoPs (A 3 /J 3 -IsoPs) can be generated from the oxidation of EPA in vitro and in vivo.
A proposed mechanism of formation of A 3 /J 3 -IsoPs is shown in Figure 1 . There are four bis-allylic carbons in EPA at carbons 7, 10, 13, and 16 as opposed to only three bis-allylic carbons in arachidonic acid. Hydrogen abstraction can occur at each of these bis-allylic carbons and is followed by oxygen insertion. Depending on the site of oxygen insertion, one of eight different hydroperoxide are generated; these eight hydroperoxides are then further oxidized to yield six bicyclic endoperoxides that can then undergo ring arrangement to form six series of E 3 /D 3 -IsoPs. These products subsequently dehydrate to generate one of six different series of A 3 /J 3 -IsoPs. Each regioisomer is theoretically comprised of eight racemic diastereomers for a total of 48 compounds. A nomenclature system for the IsoPs has been established and approved by the Eicosanoid Nomenclature Committee in which each different regioisomer class is designated by the carbon number on which the side chain hydroxyl is located with the carboxyl carbon designated as C-1 (17) . Thus, in accordance with this nomenclature system, the A 3 /J 3 -IsoP regioisomers are designated as 5-, 8-, 11-, 12-, 15-, and 18-series A 3 /J 3 -IsoPs. Herein, we present evidence that A 3 /J 3 -IsoPs are, in fact, formed in significant amounts in vitro and in vivo from the free radical-catalyzed peroxidation of EPA. Oxidation of EPA-Five milligrams of fresh EPA was dissolved in 100 µl of ethanol and added immediately to 4.9 ml of phosphatebuffered saline solution (pH 7.4) containing 10 mM AAPH. The EPA oxidation reaction mixture was incubated at 37°C for varying amounts of time after which it was placed immediately at -80 °C until being further processed.
EXPERIMENTAL PROCEDURES

Materials
Purification and Analysis of A 3 /J 3 -IsoPsFree and esterified A 3 /J 3 -IsoPs were extracted using C-18 Sep-Pak cartridges, converted to methoxylamine (MOX) derivatives in pyridine, extracted, converted to pentafluorobenzyl ester derivatives, purified by thin layer chromatography 6.5) in the presence of a 10-fold excess (~1 µg) of GSH and 1 mg of equine liver GST containing a mixture of GSTs at 37°C for 2 h (14). The incubation mixture was then acidified to pH 3 and extracted with 2 volumes of MeCl 2 . Unconjugated A 3 /J 3 -IsoPs were measured in the organic fraction by GC/MS and conjugated IsoPs represented the difference between the amount of A 3 /J 3 -IsoPs added to the incubation versus that amount present in the organic fraction (15) .
Subsequently, A 3 /J 3 -IsoP-GSH adducts from a separate incubation were definitively identified by LC/MS. Adducts were purified by extraction using a C18 Sep-Pak cartridge preconditioned with acetonitrile and 0.1 M ammonium acetate (pH 3.4) (14) and eluted with 10 ml of 95% ethanol (10 mL), dried under a stream of N 2 , and analyzed by LC/MS. Samples were suspended in a 1:3 mixture of Phase 1:Phase 2 (Phase 1: acetonitrile/methanol/acetic acid 95/5/0.1; Phase 2: water/Phase 1/acetic acid 95/5/0.1). LC was carried out using the Surveyor MS Pump equipped with a Phenomenex Luna C-18 column (50 x 2.00 mm, 3 μm) using Phase 1 and Phase 2 as mobile phases (0.3 mL/min) and an isocratic gradient of Phase 1 for 1 min and then a gradient of 20% -70% Phase 1 in 26 minutes.
Samples were analyzed using a ThermoFinnigan TSQ/Quantum Ultra mass spectrometer operating in the negative ion mode. The electrospray (ESI) source was fitted with a deactivated fused silica capillary (100 mm i.d.). Nitrogen was used as both the sheath gas and the auxiliary gas, and all parameters were tuned in order to have maximum response. For MS/MS experiments, putative A 3 /J 3 -IsoPs were collisionally activated between energies of 15 to 30 eV under 1.5 mTorr of argon. Data acquisition and analysis were performed using Xcalibur software, version 2.0.
Analysis of A 3 /J 3 -IsoPs by Liquid Chromatography (LC)/Electrospray Ionization (ESI)-MS/MS-After extraction using the C-18
Sep-Pak methodology described above, samples were suspended in 2:1 methanol:water, and A 3 /J 3 -IsoPs were analyzed by LC. LC was performed with a Surveyor MS Pump equipped with a Phenomenex Luna C-18 column (50 x 2.00 mm, 3 μm) at a flow rate of 0.2 mL/min starting with 85% Phase 1 (95/5/0.1 acetonitrile/methanol/acetic acid) to 50% from 1 to 17.50 min, holding for 30 seconds, and returning to 85% at 19.00 min. Phase 2 consisted of water/Phase 1/acetic acid (95/5/0.1). LC/MS was carried out on a ThermoFinnigan TSQ/Quantum Ultra mass spectrometer. The ESI source was fitted with a deactivated fused silica capillary (100 µm inner diameter), and the mass spectrometer was operated in the negative ion mode. Nitrogen was used as both the sheath gas and the auxiliary gas, at 31 and 17 p.s.i., respectively. The capillary temperature was 300 °C. The spray voltage was 5.0 kV, and the tube lens voltage was 80V. Collision-induced dissociation (CID) of the molecular ion of putative A 3 /J 3 -IsoPs was performed from 12 to 28 eV under 1.5 mTorr of argon. Spectra that are shown were obtained at either18 or 21 eV. Spectra were displayed by averaging scans across chromatographic peaks. Selective reaction monitoring (SRM) was performed according to characteristic fragmentation patterns of A 3 /J 3 -IsoPs determined by CID. The collision energy for SRM was 18 eV. Data acquisition and analysis were performed using Xcaliber software, version 2.0.
Preparation of A 3 /J 3 -IsoPs from Rodent Tissue-Rats were fed with a rodent AIN-93 diet containing either 0% or 4% Menhaden fish oil (by weight). In some studies, animals were administered CCl 4 (1 ml/kg) orogastrically to induce oxidative stress four hours before sacrifice. After 4 weeks of feeding, the rats were sacrificed. Liver and other tissues were removed and immediately flash-frozen in liquid nitrogen and stored at -80 °C. Analyzed tissue samples were homogenized in 5 ml of ice-cold chloroform:methanol (2:1, v/v) containing butylated hydroxytoluene (0.005%) to prevent ex vivo autoxidation. Esterified A 3 /J 3 -IsoPs in phospholipids were enzymatically hydrolyzed using bee venom PLA 2 to liberate free A 3 /J 3 -IsoPs. As noted previously (18) , the addition of various PUFAs including arachidonic acid, EPA, or DHA to tissues during workup does not increase the levels of IsoP-like compounds in tissue extracts. A 3 /J 3 -IsoPs in samples were then purified and analyzed as described above.
Analysis of A 3 /J 3 -IsoP-PCs in Vivo by Ultra Pressure Liquid Chromatography (UPLC)/Electrospray Ionization (ESI)-Ion Trap-MS-
Liver tissue samples were obtained from previously mentioned feeding studies and tissue samples were homogenized in 5 ml of ice-cold chloroform:methanol (2:1, v/v) containing butylated hydroxytoluene (0.005%) to prevent ex vivo auto-oxidation. Phospholipids were separated from other lipids as follows. An inert II silica Sep-Pak (500 mg) was pre-washed with 5 mL hexanes followed by 5 mL chloroform. Each sample was applied to a column and initially extracted with 12 mL of hexanes/methyl tert-butyl ether (MTBE) (200/3, v/v). Unoxidized cholesterol esters and triglycerides elute in this fraction. Subsequently, the column was extracted with 12 mL of methanol/MTBE (5/95, v/v) to remove non-polar lipids and cholesterol. A final extraction using 15 mL of MTBE/methanol/ammonium acetate (0.01 M) (5/8/2, v/v/v) eluted oxidized and unoxidized phospholipids. Samples were dried under N 2 and reconstituted in methanol/water (2/1). Products were analyzed by UPLC/ESI-Ion Trap-MS using a Waters Acquity UPLC (Waters Corp., Milford, MA) with a Phenomenex Luna 3μ C-8 column (150 x 4.6 mm) at a flow rate of 1.0 mL/min and a flow splitter which sent approximately 35% of the mobile phase to the mass spectrometer. A linear gradient was used starting with 75% solvent A (methanol/water/1/1, 20 mM ammonium acetate) to 0% in 1-10 min, held at 0% from 10-20 min., and returned to 75% at 25 min. Mobile phase B consisted of 20 mM ammonium acetate in methanol. MS was carried out on a ThermoFinnigan LCQ Deca-XP Ion Trap mass spectrometer. The ESI source was fitted with a deactivated fused silica capillary (100 µm inner diameter), and the mass spectrometer was operated in the negative ion mode. Nitrogen was used as the sheath gas at 38 p.s.i. The capillary temperature was 350 °C. The spray voltage was 4.5 kV, and the tube lens voltage was 100 V. CID of the molecular ion of putative A 3 /J 3 -IsoPs esterified in phospholipids was performed at 25 or 35 eV under 1.5 mTorr of argon. Spectra were displayed by averaging scans across chromatographic peaks. Data acquisition and analysis were performed using Xcaliber software, version 2.0. The peak marked with an asterisk (*) is used for calculations of IsoP formation while the peak marked with a plus (+) represents the other internal standard isomer. In the upper m/z 432 ion current chromatogram are a series of chromatographic peaks eluting over a 1-min interval. These compounds possess the molecular mass predicted for derivatized A 3 /J 3 -IsoPs. Further, these chromatographic peaks elute at a later retention time than the deuterated PGA 2 internal standard; it would be expected that A 3 /J 3 -IsoPs might elute at a different time than PGA 2 due to the presence of an additional carbon-carbon double bond in the molecule (16) . Like A 2 /J 2 -IsoPs formed from arachidonic acid oxidation and A 4 /J 4 -IsoPs formed from DHA oxidation, it is not possible to differentiate between A-ringcontaining molecules and J-ring-containing molecules as both chromatograph similarly and have an identical m/z ratio. It should also be noted that the retention times over which A 3 /J 3 -IsoPs elute may differ somewhat in the various figures in this report as analyses were performed on different days using different columns that varied in length.
RESULTS
Formation and Characterization of
Additional experimental approaches were used to provide further evidence that the compounds represented by the chromatographic peaks in the m/z 432 channel were A 3 (Fig. 5 ). Collectively these data indicate that the compounds represented by the chromatograms shown in Fig. 2 have the functional groups and the double bonds predicted for A 3 /J 3 -IsoPs.
Adduction of A 3 /J 3 -IsoPs with Glutathione in Vitro-One of our primary interests in the formation of cyclopentenone IsoPs in vivo is related to the fact that A 3 /J 3 -IsoPs contain α,β-unsaturated carbonyl moieties which render these molecules electrophilic (14) . Thus, as a further characterization step, we sought to determine whether purified A 3 /J 3 -IsoPs obtained from the oxidation of EPA in vitro conjugate with GSH in the presence of GST. We have previously shown that cyclopentenone eicosanoids including 15-A 2t -IsoP and A 4 /J 4 -NPs readily adduct GSH in the presence of GST in vitro (14, 15) . Formation of GSH conjugates of IsoPs was assessed first by determining the percent of A 3 /J 3 -IsoPs that did not extract into an organic solvent, methylene chloride, at pH 3. We found that 62 ± 5% of the A 3 /J 3 -IsoPs were in the form of a polar conjugate that would not extract after two hours of incubation with GSH and GST (data not shown). These results were analogous to those found for 15-A 2t -IsoP and for A 4 /J 4 -NPs (14, 15) . These data suggest that, like other cyclopentenone IsoPs, A 3 /J 3 -IsoPs are reactive molecules capable of undergoing nucleophilic addition.
Subsequently, putative A 3 /J 3 -IsoP-GSH adducts were definitively identified by LC/MS. Adducts were partially purified from an incubation mixture and subjected to LC as described above. The predicted [parent molecule -H + ] -ion, hereafter referred to as "M -," for A 3 /J 3 -IsoP-GSH adducts is m/z 638. SIM analysis showed multiple chromatographic peaks with this m/z eluting from 10.5 to 11.5 min, presumably representing GSH adducts of different A 3 /J 3 -IsoP stereoisomers. CID experiments confirmed the molecules at m/z 638 to be A 3 /J 3 -IsoP-GSH conjugates; a composite CID spectrum was obtained by summing scans over these peaks and is shown in Fig. 6 . As is apparent, the molecular ion M -is present at m/z 638.
-, m/z 272, and m/z 254. The structures of these latter two product ions are shown in Fig. 6 . Similar CID spectra were observed when a synthesized standard, 15-A 3t -IsoP, was incubated with GST and GSH (data not shown). Together, these data confirm that the molecules putatively identified as A 3 /J 3 -IsoPs are reactive and capable of undergoing nucleophilic addition reactions with GSH.
Time Course of A 3 /J 3 -IsoP in VitroHaving provided significant evidence for the formation of the A-and J-ring IsoPs derived from EPA in vitro, we next examined the time course for their formation. For these studies, EPA was oxidized in the presence of AAPH for varying times from 0 -36 hours. The results demonstrated that A 3 /J 3 -IsoP levels increase dramatically in a time dependent manner to a maximum of 195 ± 33 ng/mg EPA when quantified by GC/MS and to a maximum of 196 ± 23 ng/mg EPA when quantified by LC/MS methods (Fig. 7) . As with GC/MS quantification, LC/MS quantification was performed by measuring the relative abundance of material representing A 3 /J 3 -IsoPs compared to that of a deuteriated PGA 2 internal standard. Despite the fact that the quantification of these compounds using both GC/MS and LC/MS gives similar results, it should be kept in mind that our methodology relies upon the quantification of A 3 /J 3 -IsoPs in total based upon a single ion as opposed to other studies we have undertaken herein utilizing various tandem MS approaches to structurally identify different stereo-and regioisomers.
Analysis of A 3 /J 3 -IsoPs by LC/ESI-MS/MS-
To provide direct evidence that the compounds analyzed by GC/NICI-MS are A 3 /J 3 -IsoPs, LC/ESI-MS/MS in the negative ion mode was employed. The predicted M -for A 3 /J 3 -IsoPs is m/z 331. The SIM chromatogram of this ion is shown in Fig. 8A . As is evident, multiple chromatographic peaks are present that presumably represent different A 3 /J 3 -IsoPs stereoisomers. All of the chromatographic peaks in Fig. 8A were next analyzed using CID in order to obtain structural information about these molecules. The observed product ions were consistent with various series of A 3 /J 3 -IsoP regioisomers. As a representative sample, the composite CID spectra at three retention times, including RT 14.91, 17.33, and 19.51 min., are shown in Fig. 8B-D -. Other prominent product ions were present that resulted from the fragmentation of each of the six specific A 3 /J 3 -IsoP regioisomers. On the basis of our previous work and studies by other groups (16, (19) (20) (21) , these ions can be explained as follows. In Fig. 8B -) (15-series). These data suggest that the mass spectrum shown in Fig. 8B represents a mixture of two predominant A 3 /J 3 -IsoP regioisomers (15-and 18-series) that would be predicted to form. In Fig. 8C  (RT 17.33 . Taken together, these data provide direct evidence for the formation of a series of A 3 /J 3 -IsoPs generated from EPA peroxidation.
The above results were confirmed using selected reaction monitoring (SRM). The major unique identifying fragments of the six EPAderived A 3 /J 3 -IsoP regioisomers identified in our CID experiments are shown in Fig. 9 . They result from cleavage of the molecule α to hydroxyl groups on the carbon backbone. In the SRM experiments, the transition of the precursor ion (m/z 331) to the product ions in Fig. 9 was monitored, and the resulting chromatograms are shown in Fig. 10 . Fig. 10A shows the chromatograms obtained from the analysis of EPA oxidized in vitro. All six series of A 3 /J 3 -IsoP regioisomeric characteristic fragments are detected eluting between 14 and 21 min., suggesting that all of these regioisomers are formed from in vitro oxidation of EPA.
Formation of A 3 /J 3 -IsoPs in Vivo-
We then undertook experiments to determine whether A 3 /J 3 -IsoPs are formed esterified in phospholipids in vivo. Baseline levels of EPA in animals and humans are extremely low; thus, A 3 /J 3 -IsoPs are below the levels of detection (<25pg/g of tissue). To determine if these compounds are generated in vivo, we supplemented rats with a Mendehen fish oil-containing diet (4% by volume) for 4 weeks. Subsequently, animals were sacrificed and tissue lipids were extracted and analyzed for oxidation products. Putative A 3 /J 3 -IsoPs were analyzed as free compounds following enzymatic hydrolysis of oxidized compounds from phospholipids. Livers were chosen for these studies as it has been shown that fish oil supplementation markedly increases the level of EPA found in this organ in animals and humans. A representative GC/MS ion current chromatogram obtained from these analyses is shown in Fig. 11 (Fig. 12B and 12C ). In addition, product ions representing the six different A 3 /J 3 -IsoP regioisomers (m/z 229, m/z 215, m/z 175, m/z 149, m/z 109, and m/z 97) were identified ( Fig.  12B-12D ). These six regioisomers were also detected in SRM experiments (Fig. 10B) . Taken together, these experiments provide evidence that A 3 /J 3 -IsoPs are formed in abundance in vivo.
Finally, we determined the effect of enhanced oxidative stress on endogenous A 3 /J 3 -IsoPs in rats fed a 4% fish oil-supplemented diet. Levels of these compounds increased from a baseline level of 19 ± 2 ng A 3 /J 3 -IsoPs/g liver to 102 ± 15 ng/g liver after administration of CCl 4 , a potent inducer of oxidant stress (Fig. 13) . The effect of fish oil supplementation on levels of A 2 -/J 2 -IsoPs derived from arachidonic acid oxidation was also studied, and we found that EPA supplementation significantly reduced their level of formation (p<0.05, data not shown). In addition, it should be noted that we have previously undertaken studies to confirm the stability of EPA in the fish oil diet fed to rodents to ensure that the source of oxidized EPA products was not the diet and that they were generated in vivo (22) . -. We next utilized MS 3 to obtain structural data on m/z 822. As can be seen in the spectrum in Fig. 14B , it was possible to detect a product ion at m/z 331, which corresponds to the expected m/z for A 3 (Fig. 14C) (15, 19, 20, (29) (30) (31) (32) ). In addition to these product ions, the 15-series A 3 /J 3 -IsoP regioisomer specific α-fragment (m/z 215) was also detected. Similar in vivo studies were undertaken to show the presence of A 3 /J 3 -IsoPs esterified in phospholipids containing a palmitoyl (C16:0) group in the sn-1 position (data not shown). Similar data were also obtained from experiments in which EPA-containing phospholipids were oxidized in vitro. Taken together, these findings, for the first time, directly demonstrate the formation of cyclopentenone eicosanoids esterified in phospholipids in vivo.
DISCUSSION
These studies have elucidated a novel class of cyclopentenone eicosanoids, A 3 /J 3 -IsoPs, formed in vitro and in vivo from the free radicalinitiated peroxidation of EPA. The mechanism of formation of A 3 /J 3 -IsoPs is outlined in Fig. 1 . Like other classes of IsoPs, the A 3 /J 3 -IsoPs are formed in situ esterified in phospholipids and are then presumably released in the free form by a phospholipase(s). Recently, it has been shown that platelet activating factor acetylhydrolases are capable of hydrolyzing F 2 -IsoPs from phospholipids, and, thus, it is conceivable that these enzymes also hydrolyze phospholipids containing A 3 /J 3 -IsoPs. (12) . Previously, we have demonstrated that another class of IsoP-like molecules, F 3 -IsoPs, are also formed from the oxidation of EPA in vivo (16) . From our studies with arachidonic acid, it is known that F-ring compounds are formed as a result of reduction of the bicyclic endoperoxide intermediates. On the other hand, A 3 /J 3 -IsoPs are generated after rearrangement of their endoperoxides precursors to molecules with E-and D-prostane rings that subsequently dehydrate (10, 14, 15, 29) . The identification and characterization of D 3 -/E 3 -IsoPs, however, remains the subject of future work. Nonetheless, it should be noted that A 3 /J 3 -IsoPs are formed in significant amounts comparable to F 3 -IsoPs.
A major impetus driving the present studies is the fact that fish oil supplementation has been shown to be beneficial in the prevention of important human diseases such as atherosclerosis and sudden cardiac death, neurodegeneration, and various inflammatory disorders (1, 3, (33) (34) (35) (36) . Although the mechanism(s) by which the ω-3 fatty acids exert their biological activity is unknown, an important anti-atherogenic and anti-inflammatory mechanism of EPA action is its interference with the arachidonic acid cascade that generates proinflammatory eicosanoids via the cyclooxygenases and lipoxygenases (1, 37) . A recent Japanese study examining the effects of EPA on major coronary events in hypercholesterolemia (JELIS) demonstrated a 19% reduction in coronary events after 4.6 years of EPA intervention in hypercholesterolemic patients (33) . EPA has also been shown not only to replace arachidonic acid in phospholipid bilayers but is also a competitive inhibitor of cyclooxygenases, reducing the production of 2-series PGs and thromboxanes as well as 4-series leukotrienes (38) (39) (40) . The 3-series and 5-series PGs and leukotrienes derived from EPA have also been shown to be either less biologically active or are inactive in comparison to the products formed from arachidonic acid (39, 41, 42) . Thus, compounds derived from EPA are thought to exert less inflammatory activity. Further, Serhan and colleagues have described a specific group of polyoxygenated EPA derivatives termed resolvins that are produced enzymatically in various tissues; these molecules have been shown to inhibit cytokine expression and other inflammatory responses (7, (43) (44) (45) (46) (47) .
In addition to identifying enzymatically generated oxygenated derivatives of EPA, there has been significant interest in studying the beneficial effects of non-enzymatically derived EPA peroxidation products (8, 16, 48) . Sethi et. al. reported Cu ++ -oxidized EPA, but not native EPA, potently inhibits human neutrophil and monocyte adhesion to endothelial cells, a process linked to atherosclerosis (4) (5) (6) . This effect was induced via inhibition of endothelial adhesion receptor expression and was modulated by the activation of the peroxisome proliferator-activated receptor-α (PPAR-α) by ω-3 oxidation products. Further studies by this group demonstrated that oxidized EPA markedly reduced leukocyte adhesion to venular endothelium of lipopolysaccharide-treated mice in vivo and the effect was not observed in PPAR-α-deficient mice, suggesting that oxidized EPA products are partially responsible for the antiinflammatory effects ascribed to EPA consumption. Similarly, Vallve has shown that various non-enzymatic aldehyde oxidation products of EPA decrease the expression of the CD36 receptor, a receptor has been linked to atherosclerosis, in macrophages (49) . It has also been demonstrated that EPA peroxidation products modulate the generation of other endothelial inflammatory molecules (5,50) Further, Arita has reported that non-enzymatically oxidized EPA enhances apoptosis in HL-60 leukemia cells showing that oxidized ω-3 PUFAs are antiproliferative (51). Similar findings have been reported in HepG2 (human hepatoma) cells, AH109A (rat liver cancer) cells and glomerular endothelial cells (52) (53) (54) . In none of these studies, however, were the specific peroxidation products responsible for these effects been identified. Thus, the identification of specific oxidation products at a molecular level of EPA has been largely lacking.
Recently, we reported that oxidation products of EPA activate the Nrf2 transcription factor that mediates important antioxidant responses in response to reactive electrophiles via induction of gene transcription. These nonenzymatically-derived products were postulated to interact with Keap1, the direct inhibitor of Nrf2, initiating Keap1 dissociation from Cullin3 to yield Nrf2 translocation and activation. It was hypothesized therein that molecules containing an α,β-unsaturated carbonyl moiety, specifically J 3 -IsoPs, were responsible for eliciting this biological activity (8) . The previously mentioned work, however, did not definitively characterize the structure of EPA-derived cyclopentenone IsoPs. Nonetheless, this previous work was the first to ascribe specific nonenzymatic EPA peroxidation products with biological activity. Concentrations of oxidized EPA products necessary to exert this biological activity were in the micromolar range, and, interestingly, in the studies reported herein, we measured levels of A 3 /J 3 -IsoPs in the range of 0.3 μM in liver tissue from rats after induction of an oxidant stress. These finding suggest that A 3 /J 3 -IsoPs can be generated in vivo at biologically relevant concentrations. Of note, these levels of A 3 /J 3 -IsoPs represent esterified compounds. Previously, however, we have shown that IsoPs are rapidly hydrolyzed from tissue lipids to the free form (11, 12) . In addition, it is important to note that since, as a class, the biological activities of A 3 /J 3 -IsoPs are likely primarily related to the highly reactive cyclopentenone moiety. We would therefore postulate that all of the different stereo-and regioisomers of the A 3 /J 3 -IsoPs generated in vivo contribute to their biological activities.
The studies reported herein have systematically characterized the formation of A 3 /J 3 -IsoPs from the oxidation of EPA in vitro and in vivo. These molecules were identified using a variety of complementary chemical and MS approaches. As predicted, 6 series of A 3 /J 3 -IsoPs were identified. The fragmentation patterns of A 3 /J 3 -IsoPs are similar to F 3 -IsoPs, and, indeed, previously acquired information regarding the F 3 -IsoPs was extremely useful for the present work (16) . In addition, based on previous studies with F 3 -IsoPs, we would hypothesize that the 5-series and 18-series A 3 /J 3 -IsoPs should predominate given the ability of the other four series of A 3 /J 3 -IsoP regioisomers to further oxidize to yield novel dioxolane-IsoPs derived from EPA (22) . But, as is evident from data presented in Fig. 10 , all 6 series of A 3 /J 3 -IsoPs appear to be formed in fairly equal abundance (16, 20) . The reason for this discrepancy is unclear although we might propose this is due to preferential metabolism in vivo of particular A 3 /J 3 -IsoP regioisomers. In this regard, further experimentation will need to be undertaken to understand the mechanisms of formation and metabolism of A 3 /J 3 -IsoPs.
In summary, we report the discovery that A/Jring IsoPs are formed in vitro and in vivo as products of the non-enzymatic free radicalcatalyzed peroxidation of EPA, a major ω-3 fatty acid found in fish oil. The fact that A 3 /J 3 -IsoPs are readily detectable in liver tissues from animals that have been supplemented with fish oil suggests the compounds represent an important pathway for the oxidative metabolism of EPA. Further understanding of the biological consequences of the formation of these novel compounds and the factors influencing their formation and metabolism are underway and will likely provide valuable insights into the beneficial effects associated with fish oil consumption on human health.
FOOTNOTES
1
Abbreviations used are: EPA, eicosapentaenoic acid; IsoP, isoprostane; PUFA, polyunsaturated fatty acid; NP, neuroprostane; GC, gas chromatogram; MS, mass spectrometry; LC, liquid chromatography; UPLC, ultra pressure liquid chromatography; PG, prostaglandin; DHA, docosohexaenoic acid; AAPH, 2,2'-Azobis(2-amidinopropane) hydrochloride; GSH, glutathione; GST, glutathione-S-transferase; NICI, negative ion chemical ionization; TLC, thin layer chromatography; ESI, electrospray ionization; CID, collision-induced dissociation; RT, retention time; SIM, selected ion monitoring; SRM, selected reaction monitoring; MOX, N-methyloxime; TMS, trimethylsilyl; MTBE, methyl tert-butyl ether; SIsoPPC, 1-stearoyl-2-A 3 /J 3 -IsoP-phosphatidylcholine; PPAR, peroxisome proliferator-activated receptor. 2 This work was supported by NIH Grants GM15431, DK48831 and ES13125. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The m/z 351 ion was subjected to CID at 21eV, and product ions were scanned from 30 -400. B, CID spectrum by obtaining scans over the chromatographic peak at retention time 12.60 min. C, CID spectrum obtained by summing scans over the chromatographic peak at retention time 17.01 min. D, CID spectrum obtained by summing scans over the chromatographic peak at retention time 19.16 min. 
